Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 961769
Author(s) Gaab, Jens; Hüster, D.; Peisen, R.; Engert, V.; Heitz, V.; Schad, T.; Schürmeyer, Th; Ehlert, U.
Author(s) at UniBasel Gaab, Jens
Year 2003
Title Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects
Journal Psychosomatics
Volume 44
Number 2
Pages / Article-Number 113-9
Abstract A reduced secretion of cortisol has been proposed as a possible explanation of the symptoms in chronic fatigue syndrome. However, the evidence of hypocortisolism in chronic fatigue syndrome is conflicting. In order to simultaneously assess possible alterations in adrenocortical sensitivity and secretory adrenal reserve, the authors administered both low-dose and high-dose ACTH to a group of 18 chronic fatigue syndrome patients and 18 age- and gender-matched healthy comparison subjects. No response differences for salivary and plasma cortisol were detectable after administration of either low-dose or high-dose ACTH, indicating that primary adrenal insufficiency is unlikely to play a significant role in the etiology of chronic fatigue syndrome.
Publisher Physicians Postgraduate Press
ISSN/ISBN 0033-3182 ; 1545-7206
edoc-URL http://edoc.unibas.ch/46397/
Full Text on edoc No
Digital Object Identifier DOI 10.1176/appi.psy.44.2.113
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/12618533
ISI-Number WOS:000181188600004
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.336 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024